T +44 20 7532 2249
Represented Jefferies International Ltd. as underwriter and DNB Markets and ABG Sundal Collier ASA as placement agents on the NOK 500 million offering of ordinary shares. by Nordic Nanovector ASA, a Norwegian biopharmaceutical company listed on the Oslo Stock Exchange focusing on the development of antibody-radionuclide-conjugate solutions.
Represented Play Topco S.A. as issuer on the offering of €500 million 5.375% / 6.125% Senior PIK toggle notes due 2022.
Represented Guggenheim Securities LLC and Bryan, Garnier &Co as placement agents on the €18 million offering of ordinary shares listed on the Spanish Stock Exchanges by Oryzon Genomics, S.A., a Spanish biopharmaceutical company developing epigenetics-based therapeutics.
Represented Guggenheim Securities, LLC and Oddo BHF SCA on the offering of €22.5 million ordinary shares of GenSight Biologics S.A., a French biopharmaceutical company listed on Euronext Paris focusing on novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system.
Represented Guggenheim Securities LLC and Bryan, Garnier & Co. as placement agents on the €26 million offering of ordinary shares listed on Euronext Paris by Nicox S.A., a French biopharmaceutical company developing innovative solutions to maintain vision and improve ocular health.